Your session is about to expire
← Back to Search
Advanced Care Planning for Sarcoma
N/A
Waitlist Available
Led By Megan Shen
Research Sponsored by Fred Hutchinson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 4 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a checklist tool to assess future mobility needs for sarcoma patients. It may help improve quality of life by helping them plan for their future needs.
Who is the study for?
This trial is for English-speaking adults over 18 with sarcoma who've had limb surgery or are in active treatment for stage IV sarcoma. They must be able to consent and have computer access. Caregivers meeting the same criteria can also participate.
What is being tested?
The study evaluates a checklist tool designed to assess future mobility needs of sarcoma patients post-surgery or during stage IV treatment, aiming to improve their quality of life by aiding in planning for mobility challenges.
What are the potential side effects?
Since this trial involves assessments through questionnaires and interviews rather than medical treatments, there are no direct physical side effects associated with participating.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to after completion of intervention (+ 1 week)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to after completion of intervention (+ 1 week)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability of the intervention: Acceptability E-Scale
Acceptability: Satisfaction with the intervention
Feasibility, as measured by the number of subjects accrued to the study
+2 moreSecondary study objectives
Change in completion of advance directives
Change in discussion of advance directives
Change in functional status
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive Care (advanced care planning checklist)Experimental Treatment4 Interventions
FIELD TEST: Participants complete the Advance Care Planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants medical records are also reviewed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Assessment
2007
N/A
~2190
Find a Location
Who is running the clinical trial?
Fred Hutchinson Cancer CenterLead Sponsor
571 Previous Clinical Trials
1,340,951 Total Patients Enrolled
Megan ShenPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium
1 Previous Clinical Trials
46 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am the chosen informal caregiver by the patient.I am 18 years old or older.My caregiver speaks English.I am at least 18 years old.I had surgery for sarcoma in the last 6 months or have stage IV sarcoma and am receiving treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive Care (advanced care planning checklist)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.